US Broker Ratings

Haleon plc (HLN) Stock Analysis: Unpacking a 29% Potential Upside in Healthcare’s Promising Player

Investors with a keen eye on the healthcare sector may find Haleon plc (HLN) a compelling consideration, especially with its notable 29.33% potential upside. As a..

Koninklijke Philips N.V. (PHG) Stock Analysis: Navigating a 21.94% Potential Upside

As investors scour the healthcare sector for promising opportunities, Koninklijke Philips N.V. (NYSE: PHG) stands out with its substantial market capitalization of $26.88 billion and a..

Insmed Incorporated (INSM) Stock Analysis: Biotechnology Growth with a 3.28% Potential Upside

Insmed Incorporated (NASDAQ: INSM) stands as a prominent player in the biotechnology sector, commanding attention with its cutting-edge therapies targeting serious and rare diseases. With its..

McKesson Corporation (MCK) Stock Analysis: Healthcare Giant with an 8.65% Upside Potential

McKesson Corporation (NYSE: MCK) stands as a towering figure in the healthcare sector, with its operations spanning across the U.S. and international markets. With a market..

Zoetis Inc. (ZTS) Stock Analysis: Exploring a Potential 34% Upside in the Animal Health Sector

Investors keen on the healthcare sector, particularly in animal health, would do well to cast a discerning eye on Zoetis Inc. (NYSE: ZTS). With a market..

Takeda Pharmaceutical (TAK): Investor Outlook with a Promising 30% Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK), a prominent player in the healthcare sector, stands out with its robust global footprint and expansive portfolio in drug manufacturing...

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring a 12.6% Upside Potential

Universal Health Services, Inc. (NYSE: UHS), a titan in the healthcare sector, commands attention with its robust operations in the medical care facilities industry. Headquartered in..

The Cooper Companies, Inc. (COO): Investor Outlook Highlights 21.67% Potential Upside

The Cooper Companies, Inc. (COO), a prominent player in the healthcare sector, is capturing investor attention with a potential upside of 21.67%. This figure, derived from..

IDEXX Laboratories, Inc. (IDXX): Investor Outlook on Strong Revenue Growth and a 13.15% Potential Upside

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the healthcare sector, operates at the intersection of diagnostics and research with a market capitalization of $49.29..

Waters Corporation (WAT) Investor Outlook: Exploring a 6% Upside with Robust Revenue Growth

Waters Corporation (WAT), a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry, has been capturing the attention of investors with its..

Biogen Inc. (BIIB) Stock Analysis: Exploring a 17% Potential Upside Amidst Robust Neurological Portfolio

Biogen Inc. (NASDAQ: BIIB), a prominent player in the healthcare sector, is making waves with its extensive portfolio of therapies targeting neurological and neurodegenerative diseases. With..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Navigating a Promising 18% Upside in the Biotech Leader

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable name in the biotechnology sector, boasting a substantial market capitalization of $104.55 billion. As a leader in..

Boston Scientific Corporation (BSX): Investor Outlook Shows 30.9% Upside Potential with Strong Buy Ratings

Boston Scientific Corporation (NYSE: BSX) stands as a formidable presence in the healthcare sector, particularly within the medical devices industry. With a robust market capitalization of..

Danaher Corporation (DHR) Stock Analysis: Exploring a Potential 20% Upside Amidst Strong Buy Ratings

Danaher Corporation (NYSE: DHR), a stalwart in the healthcare sector, stands as a compelling investment opportunity with a market capitalization of $144.97 billion. Specializing in the..

Abbott Laboratories (ABT) Stock Analysis: A Healthcare Giant with a 7.96% Upside

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, continues to capture investor attention with its impressive market cap of $230.73 billion. As a leading..

The Cigna Group (CI) Stock Analysis: Exploring a 21.49% Upside Potential for Investors

The Cigna Group (NYSE: CI), a stalwart in the healthcare sector with a robust market cap of $80.27 billion, presents a compelling opportunity for investors seeking..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Evaluating a Potential 11% Upside in the Healthcare Sector

IQVIA Holdings, Inc. (IQV) is making waves in the healthcare sector, standing out with a robust market capitalization of $33.69 billion. As a prominent name in..

Sanofi (SNY) Stock Analysis: Potential Upside and Strong Dividend Yield Attract Investor Interest

Sanofi (SNY), a leading player in the global healthcare sector, presents a compelling case for investors looking to capitalize on both stable dividend income and significant..

HCA Healthcare, Inc. (HCA) Stock Analysis: Strong Revenue Growth Amid Sector Challenges

HCA Healthcare, Inc. (NYSE: HCA), a titan in the healthcare sector, operates a vast network of medical care facilities across the United States. With a market..

Merck & Company, Inc. (MRK) Stock Analysis: Navigating a 17.92% Potential Upside in the Healthcare Sector

Merck & Company, Inc. (NYSE: MRK) stands as a towering presence in the healthcare sector, particularly within the drug manufacturing industry. With a substantial market capitalization..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds